After a knockdown of PGC-1α expression by siRNA, the efficacy of ZLN005 was blocked in the fibrosis model in vitro, which suggests ZLN005 protection against kidney fibrosis may be partially dependent on PGC-1α. The gene discussed is PPARGC1A; the disease is fibrosis.